FDA FDA_REQUESTED_RECALL_LETTER - Pacifico National, Inc. dba AmEx Pharmacy - May 02, 2019

FDA FDA_REQUESTED_RECALL_LETTER for Pacifico National, Inc. dba AmEx Pharmacy on May 02, 2019. Product: Other. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA FDA_REQUESTED_RECALL_LETTER for Pacifico National, Inc. dba AmEx Pharmacy on May 02, 2019. Product: Other. Access full analysis and detailed observations.

Violation Codes

FD&C Act 501(a)(2)(B)

21 U.S.C. 351(a)(2)(A)

21 U.S.C. 351(a)(2)(B)

FD&C Act 501(a)(2)(A)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Pacifico National, Inc. dba AmEx Pharmacy

Inspection Date

May 2, 2019

Product Type

Other

People

ID: 455750fa-6db2-4041-993b-0bcd7e9cbc2f

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox